ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKSE:1541.HK).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer1541.HK Technical Analysis Summary
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.
Technical conditions suggest ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is consolidating, awaiting a decisive move.
RSI (14): 25.05
Stochastic %K: 7.78
Williams %R: -86.99
Rate of Change (ROC): -26.17
Takeaway:ImmuneOnco Biopharmaceuticals (Shanghai) Inc. shows oversold momentum, with rebound potential building.
MACD: -0.46
ADX: 27.13
ATR (14): 0.31
CCI (14): -105.22
Takeaway:ImmuneOnco Biopharmaceuticals (Shanghai) Inc. shows weakening trend signals, with bearish pressure building.
Takeaway:ImmuneOnco Biopharmaceuticals (Shanghai) Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:ImmuneOnco Biopharmaceuticals (Shanghai) Inc. trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:1541.HK shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:ImmuneOnco Biopharmaceuticals (Shanghai) Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.